Litcius/Paper detail

Human TRIM5α senses and restricts LINE-1 elements

Bianca Volkmann, Sabine Wittmann, Justine Lagisquet, Janina Deutschmann, Kristin Eissmann, James J. Ross, Brigitte Biesinger, Thomas Gramberg

2020Proceedings of the National Academy of Sciences39 citationsDOIOpen Access PDF

Abstract

Mobile genetic elements have significantly shaped our genomic landscape. LINE-1 retroelements are the only autonomously active elements left in the human genome. Since new insertions can have detrimental consequences, cells need to efficiently control LINE-1 retrotransposition. Here, we demonstrate that the intrinsic immune factor TRIM5α senses and restricts LINE-1 retroelements. Previously, rhesus TRIM5α has been shown to efficiently block HIV-1 replication, while human TRIM5α was found to be less active. Surprisingly, we found that both human and rhesus TRIM5α efficiently repress human LINE-1 retrotransposition. TRIM5α interacts with LINE-1 ribonucleoprotein complexes in the cytoplasm, which is essential for restriction. In line with its postulated role as pattern recognition receptor, we show that TRIM5α also induces innate immune signaling upon interaction with LINE-1 ribonucleoprotein complexes. The signaling events activate the transcription factors AP-1 and NF-κB, leading to the down-regulation of LINE-1 promoter activity. Together, our findings identify LINE-1 as important target of human TRIM5α, which restricts and senses LINE-1 via two distinct mechanisms. Our results corroborate TRIM5α as pattern recognition receptor and shed light on its previously undescribed activity against mobile genetic elements, such as LINE-1, to protect the integrity of our genome.

Topics & Concepts

RetrotransposonMobile genetic elementsInnate immune systemBiologyGenomeRibonucleoproteinGeneticsPattern recognition receptorComputational biologyEndogenous retrovirusHuman genomeGenome editingSafeguardingLine (geometry)Transposable elementCell biologyGeneImmune systemRNAMathematicsNursingMedicineGeometryPlant Virus Research StudiesCRISPR and Genetic Engineeringinterferon and immune responses